Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy

INTRODUCTION: An accurate and timely diagnosis for Alzheimer’s disease (AD) is important, both for care and research. The current diagnostic criteria allow the use of CSF biomarkers to provide pathophysiological support for the diagnosis of AD. How these criteria should be operationalized by clinici...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhodius-Meester, Hanneke F. M., van Maurik, Ingrid S., Koikkalainen, Juha, Tolonen, Antti, Frederiksen, Kristian S., Hasselbalch, Steen G., Soininen, Hilkka, Herukka, Sanna-Kaisa, Remes, Anne M., Teunissen, Charlotte E., Barkhof, Frederik, Pijnenburg, Yolande A. L., Scheltens, Philip, Lötjönen, Jyrki, van der Flier, Wiesje M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961870/
https://www.ncbi.nlm.nih.gov/pubmed/31940390
http://dx.doi.org/10.1371/journal.pone.0226784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961870/
https://www.ncbi.nlm.nih.gov/pubmed/31940390
http://dx.doi.org/10.1371/journal.pone.0226784

Ejemplares similares